Personnel de recherche : Questions médicales fréquentes
Nom anglais: Research Personnel
Descriptor UI:D012108
Tree Number:M01.526.839
Termes MeSH sélectionnés :
Interrupted Time Series Analysis
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Personnel de recherche : Questions médicales les plus fréquentes",
"headline": "Personnel de recherche : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Personnel de recherche : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-07",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Personnel de recherche"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Groupes professionnels",
"url": "https://questionsmedicales.fr/mesh/D009274",
"about": {
"@type": "MedicalCondition",
"name": "Groupes professionnels",
"code": {
"@type": "MedicalCode",
"code": "D009274",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01.526"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Personnel de recherche",
"alternateName": "Research Personnel",
"code": {
"@type": "MedicalCode",
"code": "D012108",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "I L Krom",
"url": "https://questionsmedicales.fr/author/I%20L%20Krom",
"affiliation": {
"@type": "Organization",
"name": "The Federal State Budget Educational Institution of Higher Education \"The V. I. Razumovsky Saratov State Medical University\" of Minzdrav of Russia, 410012, Saratov, Russia, irina.crom@yandex.ru."
}
},
{
"@type": "Person",
"name": "M V Erugina",
"url": "https://questionsmedicales.fr/author/M%20V%20Erugina",
"affiliation": {
"@type": "Organization",
"name": "The Federal State Budget Educational Institution of Higher Education \"The V. I. Razumovsky Saratov State Medical University\" of Minzdrav of Russia, 410012, Saratov, Russia."
}
},
{
"@type": "Person",
"name": "Luellen Fletcher",
"url": "https://questionsmedicales.fr/author/Luellen%20Fletcher",
"affiliation": {
"@type": "Organization",
"name": "Perelman School of Medicine Path BioResource University of Pennsylvania M163 John Morgan Bldg., 3620 Hamilton WalkPhiladelphiaPennsylvania19104 USA."
}
},
{
"@type": "Person",
"name": "Christina A Harrington",
"url": "https://questionsmedicales.fr/author/Christina%20A%20Harrington",
"affiliation": {
"@type": "Organization",
"name": "University Shared Resources and Knight Cancer Institute Oregon Health & Science University 3181 S.W. Sam Jackson Park RoadPortlandOregon97239 USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of COVID-19 pandemic on food availability and affordability: an interrupted time series analysis in Ghana.",
"datePublished": "2024-05-08",
"url": "https://questionsmedicales.fr/article/38720254",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-18745-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effect of clinical guidelines on the utilisation of radiographs in chiropractic clinics in Denmark - an interrupted time series analysis.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/37993957",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12998-023-00518-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of COVID-19 pandemic on Tuberculosis and HIV services in Ghana: An interrupted time series analysis.",
"datePublished": "2023-09-20",
"url": "https://questionsmedicales.fr/article/37729176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0291808"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using Preanesthesia Clinic Visits to Improve Advance Directives Completion: An Interrupted Time Series Analysis.",
"datePublished": "2023-05-14",
"url": "https://questionsmedicales.fr/article/37450641",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1213/ANE.0000000000006533"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interrupted time series segmented regression analysis for detecting waterborne disease outbreaks by syndromic surveillance.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36850065",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33321/cdi.2023.47.5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Personnes",
"item": "https://questionsmedicales.fr/mesh/D009272"
},
{
"@type": "ListItem",
"position": 3,
"name": "Groupes professionnels",
"item": "https://questionsmedicales.fr/mesh/D009274"
},
{
"@type": "ListItem",
"position": 4,
"name": "Personnel de recherche",
"item": "https://questionsmedicales.fr/mesh/D012108"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Personnel de recherche - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Personnel de recherche",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Personnel de recherche",
"description": "Comment évaluer l'efficacité d'un traitement ?\nQuelles méthodes de recherche sont utilisées ?\nComment identifier les biais dans une étude ?\nQu'est-ce qu'une revue systématique ?\nComment mesurer la validité d'un test ?",
"url": "https://questionsmedicales.fr/mesh/D012108?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Personnel de recherche",
"description": "Quels symptômes surveiller lors d'une étude ?\nComment évaluer les effets secondaires ?\nQuels indicateurs de santé sont mesurés ?\nComment documenter les symptômes des participants ?\nQuelle est l'importance des auto-évaluations ?",
"url": "https://questionsmedicales.fr/mesh/D012108?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Personnel de recherche",
"description": "Quelles stratégies de prévention sont utilisées ?\nComment évaluer l'impact des programmes de prévention ?\nQuels facteurs influencent la prévention ?\nComment sensibiliser à la prévention ?\nQuelle est l'importance du dépistage précoce ?",
"url": "https://questionsmedicales.fr/mesh/D012108?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Personnel de recherche",
"description": "Comment choisir un traitement dans une étude ?\nQuelles sont les approches de traitement courantes ?\nComment évaluer l'adhérence au traitement ?\nQuels sont les critères d'évaluation des traitements ?\nComment gérer les traitements combinés ?",
"url": "https://questionsmedicales.fr/mesh/D012108?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Personnel de recherche",
"description": "Quelles complications peuvent survenir dans les études ?\nComment gérer les complications dans une étude ?\nQuels sont les risques associés aux traitements ?\nComment évaluer les complications post-traitement ?\nQuelle est l'importance de la déclaration des complications ?",
"url": "https://questionsmedicales.fr/mesh/D012108?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Personnel de recherche",
"description": "Quels sont les facteurs de risque courants ?\nComment identifier les facteurs de risque dans une étude ?\nQuel rôle joue l'environnement dans les risques ?\nComment évaluer l'impact des facteurs de risque ?\nQuelle est l'importance de la prévention des risques ?",
"url": "https://questionsmedicales.fr/mesh/D012108?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un traitement ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques contrôlées et des analyses statistiques."
}
},
{
"@type": "Question",
"name": "Quelles méthodes de recherche sont utilisées ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les méthodes incluent les essais randomisés, les études de cohorte et les méta-analyses."
}
},
{
"@type": "Question",
"name": "Comment identifier les biais dans une étude ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biais peuvent être identifiés par l'examen des méthodes de sélection et d'analyse des données."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une revue systématique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une synthèse des études existantes sur un sujet, évaluant la qualité des preuves."
}
},
{
"@type": "Question",
"name": "Comment mesurer la validité d'un test ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La validité est mesurée par la sensibilité, la spécificité et la valeur prédictive."
}
},
{
"@type": "Question",
"name": "Quels symptômes surveiller lors d'une étude ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon l'étude, mais incluent souvent douleur, fatigue et dysfonction."
}
},
{
"@type": "Question",
"name": "Comment évaluer les effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont évalués par des questionnaires et des rapports de patients."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de santé sont mesurés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les indicateurs incluent la pression artérielle, le taux de cholestérol et les marqueurs biologiques."
}
},
{
"@type": "Question",
"name": "Comment documenter les symptômes des participants ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont documentés par des journaux de santé et des évaluations cliniques régulières."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance des auto-évaluations ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les auto-évaluations fournissent des informations précieuses sur l'état de santé perçu par le patient."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont utilisées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les stratégies incluent l'éducation, les vaccinations et les dépistages réguliers."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des programmes de prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact est évalué par des études de suivi et des analyses de données de santé publique."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'accès aux soins, le niveau d'éducation et les comportements de santé."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sensibilisation se fait par des campagnes d'information, des ateliers et des médias sociaux."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du dépistage précoce ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce permet d'identifier les maladies à un stade précoce, améliorant les résultats."
}
},
{
"@type": "Question",
"name": "Comment choisir un traitement dans une étude ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choix est basé sur des critères d'inclusion, des protocoles et des résultats antérieurs."
}
},
{
"@type": "Question",
"name": "Quelles sont les approches de traitement courantes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les approches incluent la pharmacothérapie, la thérapie physique et les interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'adhérence au traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'adhérence est évaluée par des questionnaires, des entretiens et des suivis réguliers."
}
},
{
"@type": "Question",
"name": "Quels sont les critères d'évaluation des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'efficacité, la sécurité, la tolérance et la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment gérer les traitements combinés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements combinés nécessitent une évaluation rigoureuse des interactions et des effets cumulés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir dans les études ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des effets indésirables, des non-conformités et des biais d'étude."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications dans une étude ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique une surveillance étroite, des ajustements de protocole et des rapports transparents."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés aux traitements ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des réactions allergiques, des interactions médicamenteuses et des complications chirurgicales."
}
},
{
"@type": "Question",
"name": "Comment évaluer les complications post-traitement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont évaluées par des suivis cliniques et des questionnaires de satisfaction."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la déclaration des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déclaration permet d'améliorer la sécurité des patients et d'affiner les protocoles de recherche."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque courants ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe, les antécédents médicaux et les habitudes de vie."
}
},
{
"@type": "Question",
"name": "Comment identifier les facteurs de risque dans une étude ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs sont identifiés par des questionnaires, des entretiens et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'environnement dans les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'environnement influence les risques par l'exposition à des toxines, des infections et des comportements."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact est évalué par des études épidémiologiques et des analyses statistiques."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la prévention des risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention réduit l'incidence des maladies et améliore la santé publique globale."
}
}
]
}
]
}
In Africa, approx. 675 million people were at risk of food insecurity. COVID-19 pandemic is likely to have exacerbated this situation, by damaging populations' access to and affordability of foods. Th...
Data on food availability and food retail prices collected through weekly market-level data during the period from July 2017 to September 2020 were used in this study. We performed interrupted time-se...
As a result, the impact of COVID-19 on food availability was limited. However, the results of interrupted time-series analyses indicate a significant increase in overall mean food prices in Greater Ac...
The impact of COVID-19 pandemic on food availability and prices was significant but varied by food type and regions in Ghana. Continuous monitoring and responses are critical to maintain food availabi...
In Denmark, chiropractors have a statutory right to use radiography and the government-funded national Health Insurance provides partial reimbursement. Danish National Clinical Guidelines recommends a...
Anonymised data from January 1st, 2010, to December 31st, 2020, were extracted from the Danish Regions register on health contacts in primary care. Data consisted of the total number of patients consu...
In total, 336,128 unique patients consulted a chiropractor in 2010 of which 55,449 (15.4%) had radiography. In 2020, the number of patients consulting a chiropractor had increased to 366,732 of which ...
The proportion of Danish chiropractic patients undergoing radiography was halved in the period from 2010 to 2020. However, the dissemination of clinical imaging guidelines recommendations and policy c...
The Coronavirus disease 2019 (COVID-19) burden, coupled with unprecedented control measures including physical distancing, travel bans, and lockdowns of cities, implemented to stop the spread of the v...
The study involved the analysis of secondary data obtained from the District Health Information Management System-2 (DHIMS-2) database of Ghana Health Service, from 2016 to 2020. Data were analysed us...
The study showed that during the COVID-19 pandemic period, there was an abrupt decline of 20.5% (955CI: 16.0%, 24.5%) in TB case notifications in April and 32.7% (95%CI: 28.8%, 39.1%) in May 2020, wit...
This study demonstrated that the COVID-19 pandemic negatively impacted TB case notifications and HIV testing and counselling services, However, ART initiation was generally not impacted during the fir...
Advance directives documentation can increase the likelihood that patient's wishes are respected if they become incapacitated. Unfortunately, completion rates are suboptimal overall, and disparities m...
We conducted a before-after interrupted time series evaluation between January 1, 2015 and June 30, 2019 in a single-center, outpatient preanesthesia clinic. Participants were adults who visited the p...
We included 26,368 visits from 22,430 patients. We analyzed financial status for 16,788 visits from 14,274 patients who had address data. There were 11,242 (43%) visits preintervention and 15,126 (57%...
Standardizing advance directives discussions during preanesthesia visits was associated with more patients completing advance directives, particularly in vulnerable patient groups....
Pathogens can enter the drinking water supply and cause gastroenteritis outbreaks. Such events can affect many people in a short time, making them a high risk for public health. In Australia, the Vict...
The study involved an interrupted time series study of a past lapse in water treatment. The baseline period comprised the four weeks before the minimum incubation period of suspected pathogens, set at...
In the retrospective analysis, there was strong evidence for an increase in presentations shortly after the event. In the simulations, with no excess presentations (i.e., with the ED data as is) the m...
The transient increase in presentations after the event may be attributed to microbiological hazards or increased health-seeking behaviour following the issuing of boil water advisories. The simulatio...
Interpersonal violence is a major public health concern with alcohol use a known risk factor. Despite alcohol taxation being an effective policy to reduce consumption; Hong Kong, contrary to most deve...
To assess the impact of the alcohol tax reductions, we analysed population-based hospitalisation data for assault from the Hong Kong Hospital Authority, and violent and sexual crimes recorded by the H...
The 2007 tax cut was associated with sustained increases in violence-related hospitalisation rates for 35-49 age group (female: 0.19%, p=0.007; male: 0.22%, p<0.001; overall: 0.16%, p=0.007); and an i...
Both alcohol tax reductions in 2007 and 2008 were in some age groups associated with increases in violence-related hospitalisations and reports of sexual assault even in an environment of low crime....
Globally, the COVID-19 pandemic has affected the number of road accidents and deaths caused by them. The present study aimed to identify the effect of this epidemic on traffic accidents and their casu...
In this study, Interrupted Time Series Analysis (ITSA) was used in a semi-experimental design to measure the impact of the restrictive policies of COVID-19 on road accidents. Data were collected retro...
Since February 2020 in Iran, the reduction in the number of road accidents and the number of injuries and deaths in these accidents was significant at 5% but the reduction of deaths in the scene and h...
In the early months of the COVID-19 epidemic in Iran, the number of road accidents and their casualties decreased. Policies restricting traffic, quarantine, and fines for violators can be reasons for ...
With the expected surge of adult patients with COVID-19, the Children's Hospital Association recommended a tiered approach to divert children to pediatric centers. Our objective was understanding chan...
Children aged < 18 y injured between January 1, 2016 and September 30, 2020, who met National Trauma Databank inclusion criteria from 9 PTCs were included. An interrupted time-series analysis was used...
Twenty seven thousand thirty one/47,382 injured patients (57.05%) were transferred to a participating PTC during the study period. Of the COVID cohort, 65.4% (4620/7067) were transferred, compared to ...
Transferred trauma patients to Level I PTC increased during the COVID-19 pandemic. The proportion of transferred patients discharged from emergency departments increased. Pediatric trauma transfers ma...
The Belgian government has taken several measures to increase the uptake of biosimilars in past years. However, no formal evaluation of the impact of these measures has been made yet. This study aimed...
An interrupted time series analysis was performed using an autoregressive integrated moving average (ARIMA) model with the Box-Jenkins method. All data were expressed as defined daily doses (DDD) per ...
In the ambulatory care, the effect of a financial prescriber incentive of 2019 was investigated. After this intervention, 44.504 (95% CI -61.61 to -14.812; P < 0.001) fewer etanercept biosimilar DDDs ...
The results of this study suggest that the impact of past policy interventions to increase the uptake of biosimilars has been variable and limited. A holistic policy framework is required to develop a...
The effectiveness of pharmacologic prophylaxis against catheter-associated thrombosis in children is unclear. We evaluated the compliance and outcomes associated with a prophylactic enoxaparin protoco...
The protocol was implemented as a quality improvement initiative and then analyzed using interrupted time series method. Data collected from November 2014 to December 2018 were divided into preprotoco...
A 12-bed academic pediatric cardiac ICU....
Children less than or equal to 18 years old with congenital heart disease admitted postoperatively with central venous catheter in situ for greater than or equal to 1 day....
Before 2016, prophylactic enoxaparin was administered according to physician preference. In January 2016, an enoxaparin protocol was implemented with a goal anti-Xa range of 0.25-0.49 international un...
We analyzed 780 hospitalizations from 636 children. Median percentage of catheter-days on prophylactic enoxaparin was 33% (interquartile range [IQR], 23-47%), 42% (IQR, 30-51%), and 38% (IQR, 35-52%) ...
The temporal association between increase in percentage of catheter-days on enoxaparin and decrease in rate of thrombosis suggests the effectiveness of prophylactic enoxaparin....
